Literature DB >> 29123613

Case of morphine-induced ventricular fibrillation.

Roman Skulec1,2,3, Jitka Callerova2, Jiri Knor2,4, Petr Ostadal5, Petr Kmonicek5, Vladimir Cerny1,3,6,7.   

Abstract

Entities:  

Year:  2017        PMID： 29123613      PMCID： PMC5675976          DOI： 10.5847/wjem.j.1920-8642.2017.04.013

Source DB:  PubMed          Journal:  World J Emerg Med        ISSN： 1920-8642


× No keyword cloud information.
  10 in total

1.  Opioid antagonist modulation of ischaemia-induced ventricular arrhythmias: a peripheral mechanism.

Authors:  D B Murphy; M B Murphy
Journal:  J Cardiovasc Pharmacol       Date:  1999-01       Impact factor: 3.105

2.  ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation.

Authors:  Ph Gabriel Steg; Stefan K James; Dan Atar; Luigi P Badano; Carina Blömstrom-Lundqvist; Michael A Borger; Carlo Di Mario; Kenneth Dickstein; Gregory Ducrocq; Francisco Fernandez-Aviles; Anthony H Gershlick; Pantaleo Giannuzzi; Sigrun Halvorsen; Kurt Huber; Peter Juni; Adnan Kastrati; Juhani Knuuti; Mattie J Lenzen; Kenneth W Mahaffey; Marco Valgimigli; Arnoud van 't Hof; Petr Widimsky; Doron Zahger
Journal:  Eur Heart J       Date:  2012-08-24       Impact factor: 29.983

3.  Hemodynamic effects of morphine and pentazocine differ in cardiac patients.

Authors:  E L Alderman; W H Barry; A F Graham; D C Harrison
Journal:  N Engl J Med       Date:  1972-09-28       Impact factor: 91.245

4.  A method for estimating the probability of adverse drug reactions.

Authors:  C A Naranjo; U Busto; E M Sellers; P Sandor; I Ruiz; E A Roberts; E Janecek; C Domecq; D J Greenblatt
Journal:  Clin Pharmacol Ther       Date:  1981-08       Impact factor: 6.875

5.  Morphine-induced cardiogenic shock.

Authors:  Colin Feeney; Chizobam Ani; Naini Sharma; Tom Frohlich
Journal:  Ann Pharmacother       Date:  2011-05-17       Impact factor: 3.154

6.  Morphine and outcomes in acute decompensated heart failure: an ADHERE analysis.

Authors:  W F Peacock; J E Hollander; D B Diercks; M Lopatin; G Fonarow; C L Emerman
Journal:  Emerg Med J       Date:  2008-04       Impact factor: 2.740

7.  Protective effect of the vagotonic action of morphine sulphate on ventricular vulnerability.

Authors:  R A EdSilva; R L Verrier; B Lown
Journal:  Cardiovasc Res       Date:  1978-03       Impact factor: 10.787

8.  Hemodynamic effects of morphine and nalbuphine in acute myocardial infarction.

Authors:  G Lee; R I Low; E A Amsterdam; A N DeMaria; P W Huber; D T Mason
Journal:  Clin Pharmacol Ther       Date:  1981-05       Impact factor: 6.875

9.  Morphine depression of myocardial function.

Authors:  T R Riggs; Y Yano; T Vargish
Journal:  Circ Shock       Date:  1986

10.  2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC)Developed with the special contribution of the Heart Failure Association (HFA) of the ESC.

Authors:  Piotr Ponikowski; Adriaan A Voors; Stefan D Anker; Héctor Bueno; John G F Cleland; Andrew J S Coats; Volkmar Falk; José Ramón González-Juanatey; Veli-Pekka Harjola; Ewa A Jankowska; Mariell Jessup; Cecilia Linde; Petros Nihoyannopoulos; John T Parissis; Burkert Pieske; Jillian P Riley; Giuseppe M C Rosano; Luis M Ruilope; Frank Ruschitzka; Frans H Rutten; Peter van der Meer
Journal:  Eur Heart J       Date:  2016-05-20       Impact factor: 29.983
  10 in total
  1 in total

Review 1.  Effects of opioid receptor agonist and antagonist medications on electrocardiogram changes and presentation of cardiac arrhythmia: review article.

Authors:  Farshid Etaee; Morgan Tobin; Suchith Vuppala; Alireza Komaki; Brian P Delisle; Luigi Di Biase; John N Catanzaro; Andrea Natale; Claude S Elayi
Journal:  J Interv Card Electrophysiol       Date:  2021-10-21       Impact factor: 1.900
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.